Pneumococcal phosphoglycerate kinase interacts with plasminogen and its tissue activator

Thrombosis and Haemostasis

Volumn 111, Issue 3, 2013, Pages 401-416

  Fulde, Marcus ^a,b   Bernardo García, Noelia ^c   Rohde, Manfred ^a   Nachtigall, Nadine ^a   Frank, Ronald ^a   Preissner, Klaus T ^d   Klett, Javier ^e   Morreale, Antonio ^e,f   Singh Chhatwal, G ^a   Hermoso, Juan A ^c   Bergmann, Simone ^a,g  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c INSTITUTO DE QUÍMICA FÍSICA ROCASOLANO   (Spain)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^f REPSOL YPF   (Spain)

^g TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Angiostatin; Phosphoglycerate kinase; Plasminogen; Streptococcus pneumoniae; Tissue type plasminogen activator

Indexed keywords

ANGIOSTATIN; BACTERIAL PROTEIN; PHOSPHOGLYCERATE KINASE; PLASMIN; PLASMINOGEN; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME IMMOBILIZATION; FIBRINOLYSIS; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; KRINGLE DOMAIN; MOLECULAR CLONING; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN PURIFICATION; SEQUENCE ALIGNMENT; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ANALYSIS; SURFACE PLASMON RESONANCE; X RAY CRYSTALLOGRAPHY;

ANGIOSTATIN; PHOSPHOGLYCERATE KINASE; PLASMINOGEN; STREPTOCOCCUS PNEUMONIAE; TISSUE-TYPE PLASMINOGEN ACTIVATOR;

ANIMALS; BACTERIAL PROTEINS; CLONING, MOLECULAR; CRYSTALLOGRAPHY, X-RAY; FIBRINOLYSIN; HUMANS; LARYNGEAL MUCOSA; MICE; NASAL MUCOSA; PHOSPHOGLYCERATE KINASE; PLASMINOGEN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT; STREPTOCOCCUS PNEUMONIAE; SURFACE PLASMON RESONANCE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84897038608     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-05-0421     Document Type: Article

References (55)

1. Cartwright K. Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr 2002; 161: 188-195.
2. Kadioglu A, Weiser JN, Paton JC, et al. The role of Streptococcus pneumoniae virulence factors in host respiratory colonisation and disease. Nat Rev Microbiol 2008; 6: 288-301.
3. Bergmann S, Hammerschmidt S. Versatility of pneumococcal surface proteins. Microbiology 2006; 152: 295-303.
4. Pérez-Dorado I, Galan-Bartual S, Hermoso JA. Pneumococcal surface proteins: when the whole is greater than the sum of its parts. Mol Oral Microbiol 2012; 4: 221-245.
5. Bergmann S, Rohde M, Preissner KT, et al. The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration. Thromb Haemost 2005; 94: 304-311.
6. Bergmann S, Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb Haemost 2007; 98: 512-520.
7. Miyashita C, Wenzel E, Heiden M. Plasminogen: a brief introduction into its biochemistry and function. Haemostasis 1988; 18 (Suppl 1): 7-13.
8. Chavakis T, Athanasopoulos A, Rhee JS, et al. Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment. Blood 2005; 105: 1036-1043.
9. Duboscq C, Genoud V, Parborell MF, et al. Impaired clot lysis by rt-PA catalysed mini-plasminogen activation. Thromb Res 1997; 86: 505-513.
10. Castellino FJ, Powell JR. Human plasminogen. Methods Enzymol 1981; 80: 365-378.
11. Winkler F, Kastenbauer S, Koedel U, et al. Role of the urokinase plasminogen activator system in patients with bacterial meningitis. Neurology 2002; 59: 1350-1355.
12. Donofrio FC, Calil AC, Miranda ET, et al. Enolase from Paracoccidioides brasiliensis: isolation and identification as a fibronectin-binding protein. J Med Microbiol 2009; 58: 706-713.
13. Carneiro CR, Postol E, Nomizo R, et al. Identification of enolase as a lamininbinding protein on the surface of Staphylococcus aureus. Microbes Infect 2004; 6: 604-608.
14. Bergmann S, Rohde M, Chhatwal GS, et al. alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface. Mol Microbiol 2001; 40: 1273-1287.
15. Hughes MJ, Moore JC, Lane JD, et al. Identification of major outer surface proteins of Streptococcus agalactiae. Infect Immun 2002; 70: 1254-1259.
16. Bernstein BE, Michels PA, Hol WG. Synergistic effects of substrate-induced conformational changes in phosphoglycerate kinase activation. Nature 1997; 385: 275-278.
17. Pecorari F, Guilbert C, Minard P, et al. Folding and functional complementation of engineered fragments from yeast phosphoglycerate kinase. Biochemistry 1996; 35: 3465-3476.
18. Bergmann S, Lang A, Rohde M, et al. Integrin-linked kinase is required for vitronectin-mediated internalisation of Streptococcus pneumoniae by host cells. J Cell Sci 2009; 122: 256-267.
19. Frank R, Overwin H. SPOT synthesis. Epitope analysis with arrays of synthetic peptides prepared on cellulose membranes. Methods Mol Biol 1996; 66: 149-169.
20. Bergmann S, Wild D, Diekmann O, et al. Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Mol Microbiol 2003; 49: 411-423.
21. Bernardo-Garcia N, Bartual SG, Fulde M, et al. Crystallisation and preliminary X-ray diffraction analysis of phosphoglycerate kinase from Streptococcus pneumoniae. Acta Crystallogr Sect F Struct Biol Cryst Commun 2011; 67: 1285-1289.
22. Leslie AG. The integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr 2006; 62: 48-57.
23. Auerbach G, Huber R, Grättinger M, et al. Closed structure of phosphoglycerate kinase from Thermotoga maritima reveals the catalytic mechanism and determinants of thermal stability. Structure 1997; 5: 1475-1483.
24. Adams PD, Afonine PV, Bunkoczi G, et al. PHENIX: a comprehensive Pythonbased system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 2010; 66: 213-221.
25. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60: 2126-2132.
26. Lyskov S, Gray JJ. The Rosetta Dock server for local protein-protein docking. Nucleic Acids Res 2008; 36: W233-238.
27. Duan Y, Wu C, Chowdhury S, et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 2003; 24: 1999-2012.
28. Lee MC, Duan Y. Distinguish protein decoys by using a scoring function based on a new AMBER force field. Short molecular dynamincs simulations, and the generalized born solvent model. Proteins 2004; 55: 620-634.
29. Case DA, Cheatham TE 3rd, Darden T, et al. The Amber biomolecular simulation programs. J Comput Chem 2005; 26: 1668-1688.
30. Morreale A, Gil-Redondo R, Ortiz AR. A new implicit solvent model for protein-ligand docking. Proteins 2007; 67: 606-616.
31. van der Linden M, Al-Lahham A, Nicklas W, et al. Molecular characterisation of pneumococcal isolates from pets and laboratory animals. PLoS One 2009; 4: e8286.
32. Ehinger S, Schubert WD, Bergmann S, et al. Plasmin(ogen)-binding alpha-enolase from Streptococcus pneumoniae: crystal structure and evaluation of plasmin(ogen)-binding sites. J Mol Biol 2004; 343: 997-1005.
33. Law RH, Caradoc-Davies T, Cowieson N, et al. The X-ray crystal structure of full-length human plasminogen. Cell Rep 2012; 1: 185-190.
34. de Vos AM, Ultsch MH, Kelley RF, et al. Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution. Biochemistry 1992; 31: 270-279.
35. Huai Q, Mazar AP, Kuo A, et al. Structure of human urokinase plasminogen activator in complex with its receptor. Science 2006; 311: 656-659.
36. Ullberg M, Wiman B, Kronvall G. Binding of tissue-type plasminogen activator (t-PA) to Neisseria meningitidis and Haemophilus influenzae. FEMS Immunol Med Microbiol 1994; 9: 171-177.
37. Abad MC, Arni RK, Grella DK, et al. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin. J Mol Biol 2002; 318: 1009-1017.
38. Kinnby B, Booth NA, Svensater G. Plasminogen binding by oral streptococci from dental plaque and inflammatory lesions. Microbiology 2008; 154: 924-931.
39. Boone TJ, Burnham CA, Tyrrell GJ. Binding of group B streptococcal phosphoglycerate kinase to plasminogen and actin. Microb Pathog 2011; 51: 255-261.
40. Boone TJ, Tyrrell GJ. Identification of the actin and plasminogen binding regions of group B streptococcal phosphoglycerate kinase. J Biol Chem 2012; 287: 29035-29044.
41. Pancholi V, Fischetti VA. alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 1998; 273: 14503-14515.
42. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 2001; 58: 902-920.
43. Fu Q, Figuera-Losada M, Ploplis VA, et al. The lack of binding of VEK-30, an internal peptide from the group A streptococcal M-like protein, PAM, to murine plasminogen is due to two amino acid replacements in the plasminogen kringle-2 domain. J Biol Chem 2008; 283: 1580-1587.
44. Wu TP, Padmanabhan KP, Tulinsky A. The structure of recombinant plasminogen kringle 1 and the fibrin binding site. Blood Coagul Fibrinolysis 1994; 5: 157-166.
45. Marti DN, Schaller J, Llinas M. Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains. Biochemistry 1999; 38: 15741-15755.
46. Christen MT, Frank P, Schaller J, et al. Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape. Biochemistry 2010; 49: 7131-7150.
47. Stec B, Yamano A, Whitlow M, et al. Structure of human plasminogen kringle 4 at 1.68 a and 277 K. A possible structural role of disordered residues. Acta Crystallogr D Biol Crystallogr 1997; 53: 169-178.
48. Chang Y, Mochalkin I, McCance SG, et al. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen. Biochemistry 1998; 37: 3258-3271.
49. Trexler M, Vali Z, Patthy L. Structure of the omega-aminocarboxylic acid-binding sites of human plasminogen. Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4. J Biol Chem 1982; 257: 7401-7406.
50. Vali Z, Patthy L. The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain. J Biol Chem 1984; 259: 13690-13694.
51. Fulde M, Rohde M, Hitzmann A, et al. SCM, a novel M-like protein from Streptococcus canis, binds (mini)-plasminogen with high affinity and facilitates bacterial transmigration. Biochem J 2011; 434: 523-535.
52. Fulde M, Rohde M, Polok A, et al. Cooperative plasminogen recruitment to the surface of Streptococcus canis via M protein and enolase enhances bacterial survival. mBio 2013; 12: e00629-12.
53. Sanderson-Smith M, Walker MJ, Ranson M. The Maintenance of High Affinity Plasminogen Binding by Group A Streptococcal Plasminogen-binding M-like Protein Is Mediated by Arginine and Histidine Residues within the a1 and a2 Repeat Domains. J Biol Chem 2006; 281: 25965-25971.
54. Parkkinen J, Hacker J, Korhonen TK. Enhancement of tissue plasminogen activator-catalysed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis. Thromb Haemost 1991; 65: 483-486.
55. DesJardin LE, Boyle MD, Lottenberg R. Group A streptococci bind human plasmin but not other structurally related proteins. Thromb Res 1989; 55: 187-193.